Literature DB >> 21820424

Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients.

Hemamalini Malligarjunan1, Pushpa Gnanaraj, Swapna Subramanian, Tamilselvi Elango, Haripriya Dayalan.   

Abstract

OBJECTIVE: Propylthiouracil (PTU) is an effective drug for psoriasis treatment. Prolactin (PRL) is increased during psoriasis which has hyperproliferative effect on keratinocytes. Hence, the objective is to find the effect of PTU on PRL level in psoriatic patients. DESIGN AND METHODS: 25 psoriatic patients and 10 control subjects were involved in the study. Serum PRL, hematological and biochemical parameters, thyroid profile and histopathological examination were performed.
RESULTS: PTU treatment for 6 weeks and 12 weeks cleared psoriatic lesions indicated by decreased PASI score (p<0.001). Patients before treatment showed significantly increased PRL levels (male p<0.01, female p<0.001) when compared to controls, which was found to decrease significantly (male p<0.01, female p<0.001) after 12 weeks. Hematological and biochemical parameters showed no significant change. Histopathology showed reduced thickening of the epidermis and acanthosis after PTU treatment.
CONCLUSION: Since PRL is a growth hormone involved in hyperproliferation of keratinocytes, this study reveals the antiproliferative effect of PTU. Furthermore, no major side effects were observed following PTU treatment.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820424     DOI: 10.1016/j.clinbiochem.2011.07.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  The HLA-Cw*06 allele and -1149 G/T polymorphism of extrapituitary promoter of PRL gene as a possible common genetic predisposing factors to psoriasis vulgaris and psoriatic arthritis in Czech population.

Authors:  Anna Cibulova; Marta Zajacova; Marketa Fojtikova; Jiri Stolfa; Liliana Sedova; Pavlina Cejkova; Jan Lippert; Petr Arenberger; Marie Cerna
Journal:  Rheumatol Int       Date:  2012-07-22       Impact factor: 2.631

2.  Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin.

Authors:  Ewan A Langan; Silvia Vidali; Natascha Pigat; Wolfgang Funk; Erika Lisztes; Tamás Bíró; Vincent Goffin; Christopher E M Griffiths; Ralf Paus
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 3.  Etiological Association Between Psoriasis and Thyroid Diseases.

Authors:  Srilatha Eapi; Rupak Chowdhury; Odunayo S Lawal; Nimisha Mathur; Bilal Haider Malik
Journal:  Cureus       Date:  2021-01-12

4.  Follicular-Stimulating Hormone, Luteinizing Hormone, and Prolactin Serum Level in Patients with Oral Lichen Planus in Comparison to Healthy Population.

Authors:  Fatemeh Lavaee; Nazila Bazrafkan; Fateme Zarei; Maryam Shahrokhi Sardo
Journal:  Biomed Res Int       Date:  2021-10-26       Impact factor: 3.411

5.  Induction of differentiation in psoriatic keratinocytes by propylthiouracil and fructose.

Authors:  Santhosh Arul; Haripriya Dayalan; Muhilan Jegadeesan; Prabhavathy Damodharan
Journal:  BBA Clin       Date:  2016-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.